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ABSTRACT
Traditional Chinese Medicine (TCM) may be integrated
with conventional Western medicine to enhance the
care of patients with cancer. Although TCM is nor-
mally implemented as a whole system, recent reduc-
tionist research suggests mechanisms for the effects
of acupuncture, herbs, and nutrition within the sci-
entific model of biomedicine. The health model of
Chinese medicine accommodates physical and phar-
macologic interventions within the framework of a
body–mind network. A Cartesian split does not occur
within this model, but to allow for scientific explora-
tion within the restrictions of positivism, reduction-
ism, and controls for confounding factors, the
components must necessarily be separated. Still,
whole-systems research is important to evaluate ef-
fectiveness when applying the full model in clinical
practice. Scientific analysis provides a mechanistic
understanding of the processes that will improve the
design of clinical studies and enhance safety. Enough
preliminary evidence is available to encourage qual-
ity clinical trials to evaluate the efficacy of integrat-
ing TCM into Western cancer care.
KEY WORDS
Chinese medicine, herbs, acupuncture, supportive
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1. INTRODUCTION
Recent evidence suggests that many therapies from
Traditional Chinese Medicine (TCM) can be effective
for the supportive care of cancer patients. The present
narrative review of the published literature provides
various levels of evidence that support further re-
search into a developing model of integrative care.
A plethora of well-designed preclinical studies
are available, but randomized controlled trials are
scarce. This situation is not a consequence of inad-
equate mechanistic knowledge; rather, it is second-
ary to challenges in clinical trial design and funding.
Most published clinical studies are at evidence
level III—in other words, they are trials without ran-
domization or they involve single group pre–post,
cohort, time series, or matched case–control studies.
We emphasize level I and II evidence from well-de-
signed randomized controlled trials of appropriate
size. In view of the paucity of quality data providing
level I and II evidence, meta-analysis is usually not
possible. In view of the promising mechanistic knowl-
edge and clinical observations, we encourage well-
designed randomized controlled trials.
2. THE CONTRAST BETWEEN TCM AND
BIOMEDICINE
It is important that TCM as a whole system not be dis-
counted simply because an individual study that evalu-
ates a single intervention for a specific disease entity
is negative. The same mindset obviously applies to
Western biomedical medicine. A negative drug study
does not negate the whole of biomedicine. Moreover,
the situation is complicated by the different defini-
tions of disease in Eastern and Western medicine, and
the philosophy of concurrent multiple interventions,
individualization, and modification of approach dur-
ing a course of treatment.
The challenge for TCM is to develop repeatable
and provable outcomes, standardization, and quality
assurance. The scientific bases of herbs and acupunc-
ture are rapidly being established, but well-designed,
pragmatic, controlled clinical studies are lacking in
most domains. To enhance patient care, TCM could be
practiced alongside conventional Western medicine.
The philosophy of TCM proposes novel hypotheses
that will support the development of a science-based
holistic medicine.
Biomodulation is the reactive or associative ad-
justment of the biochemical or cellular status of an
organism. Most modulation events describe an inter-
action in which a molecule (modulating entity) alters
the ability of an enzyme to catalyze a specific reac-
tion. In the context of cancer, biomodulation includes
the use of a substance to augment the host’s
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antitumour response, including immunotherapy. It
encompasses the regulation of innate electro-
physiologic, chemical, and molecular pathways
through relatively low-intensity physical and chemi-
cal interventions. In contrast to conventional biomedi-
cine (drugs, for example), therapies such as herbs or
their extracts are a mixture of chemicals administered
at relatively low doses over a prolonged period of
time. Acupuncture results in low-level electrochemi-
cal changes in the soft tissue fascia.
In TCM, the practice model includes the targeting
of individual imbalances using a diagnostic philoso-
phy derived from cumulative clinical observation. In
Western medicine, the combination of TCM herbs with
drug therapies is controversial, because knowledge
of whether the drug is favourably enhanced or
whether adverse effects occur is lacking. Future clini-
cal research needs to evaluate the combinations using
initial data from the preclinical studies, some of which
report favourable synergy. Parts one and two of this
article will both describe examples of biomodulation
and the results of combining TCM with biomedicine.
Part one discusses the broad principles of TCM; part
two discusses its potential clinical applications in
oncology.
3. DISCUSSION
3.1 Cancer As a Systemic Disease
In Western medicine, cancer is conventionally con-
sidered from the somatic viewpoint: a clone of cells
that have outgrown environmental constraints and
control mechanisms. The cells are abnormal and are
considered to be foreign to the body.
The main philosophy of cancer treatment is di-
rect annihilation of the cancer cells, using aggressive
and destructive therapies. Traditional Chinese Medi-
cine emphasizes the importance of the body–mind
communication network. By demonstrating the ef-
fects of emotions on cellular immunity and other
mechanisms, the science of psychoneuroimmunology
has set out a potential physiologic basis for cancer
cell progression.
In TCM, the development of cancer is viewed as
one of the presenting features of a syndrome repre-
senting an imbalance of the whole body–mind net-
work 1. In other words, cancer is a systemic disease
from the start, and the terrain is considered to be as
important as the tumour itself 2. Practitioners of TCM
believe that if the body–mind network is strength-
ened and rebalanced, the normal pattern will be re-
stored, thereby helping to resolve the cancer. This
concept is currently being incorporated into a more
holistic science, in which the whole picture is as im-
portant as the parts. To quote Hanahan and
Weinberg 3, “The metaphors used to conceptualize
cancer cell function will also shift dramatically. For
decades now, we have been able to predict with pre-
cision the behavior of an electronic integrated circuit
in terms of its constituent parts—its interconnecting
components, processing, and emitting signals. Hav-
ing fully charted the wiring of every cellular signal-
ing pathway, it will be possible to lay out the complete
‘integrated’ circuit. We will then be able to apply the
tools of mathematical modelling to cancer cells. With
holistic clarity of mechanism, cancer prognosis and
treatment will become a rational science.”
Recent evidence suggests that bone marrow stem
cells may play a significant role in the perpetuation
of some cancers, including the production of pro-
angiogenic peptides. Thus Western science is now
exploring the possibility that both hematologic and
solid cancers may sometimes be a systemic disease
from the outset 4–6.
3.2 The Body–Mind Network
Traditional Chinese Medicine recognizes that the
human being functions as a body–mind network 7.
The philosophy of TCM analyzes the “process” of
body–mind communication, rather than a “snapshot”
of structural material entities such as molecules. If
Western medicine is viewed as the hardware of a com-
puter, then TCM could represent the software—al-
though humans are more complex than the computer
metaphor suggests, because the “software and hard-
ware” can modify each other 8. Moreover, TCM theory
recognizes a correspondence between patterns of in-
formation that are independent of the carrier of the
information. For example, a pattern of information
may be similar regardless of whether it is mediated
by pulses of hormones and neuropeptides or by an
electrophysiologic frequency pattern 9–13.
Acupuncture stimulation of specific points on the
body induces not only local release of cytokines, but
also electrophysiologic communication through the
fascia and peripheral nerves. Propagation of the
electrophysiologic waves eventually releases neu-
ropeptides (such as somatostatin and vasoactive in-
testinal peptide) within the central nervous system 14,15.
The totality of communication is thus multifactorial
and time-dependent. The effects of short-term stimu-
lation may be quite different from those of a longer
course of acupuncture therapy that could, perhaps,
induce neural remodelling 16.
The body–mind information system may be partly
regulated by the relative contributions of the sympa-
thetic and parasympathetic components of the auto-
nomic nervous system. This model of regulation
corresponds to the TCM concept of balance between yin
and yang, which represents a pattern of information,
rather than concrete material entities. An analysis of
the pulse by the classical Chinese technique may indi-
cate the relative imbalance, as has been demonstrated
indirectly by using appropriate computer software to
produce a spectral analysis of electrocardiograms.
Acupuncture has been shown to rebalance the relativeCHINESE MEDICINE AND BIOMODULATION IN CANCER PATIENTS
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contributions of the sympathetic and parasympathetic
nervous systems 17. Patterns of information transfer
may interact to entrain and reinforce information flow
in a complex dynamical system 18–20. The system is
an autopoietic process. In other words, it can recreate
itself and evolve through learning, so that the body
can adapt to changing circumstances.
When an individual is healthy, communication
flows freely between systems in a complex, nonlinear,
heterarchical and hierarchical process of information
transfer through physiologic interactions. Metaphori-
cally, mind–body communication is represented by
an informatics system of energy in motion—in other
words, “e-motion.”
Cancer may be associated with a disturbance in
the information flow, manifested by an overplastic
system that loses process structure and becomes ir-
reversibly chaotic 21 in association with local elec-
trophysiologic changes 22. Experiments in rats show
that chronic restraint stress promotes lymphocyte
apoptosis through modulation of fas (sometimes
called CD95) gene expression via a pathway that in-
volves opioid receptors 23. In other words, stress can
influence both the function and the structure of the
nervous system, in turn possibly modulating lympho-
cyte gene expression, thereby influencing immunity
and resistance to cancer. Intervention with a technique
such as acupuncture may restore the general imbal-
ance in information flow—for example, by rebalanc-
ing the sympathetic and parasympathetic components
of the autonomic nervous system 24,25. The same
model of interaction with subconscious stress sys-
tems helps to achieve an understanding of how the
compassionate intentionality of a healer can restore
health through entrainment and normalization of an
imbalanced system 26.
Although these communication pathways may
play a very limited role for advanced cancer patients,
calming the stress system could conceivably slow
cancer progression and recurrence by reducing the
numbers of immunocytes, such as myeloid suppres-
sor cells and T regulator cells, that protect cancer
cells 27. Understanding these processes requires con-
sideration of systems outside the current reductionist
pharmacologic model. The multiple and widely dis-
tributed systems involved in psychoneuroimmunol-
ogy are complex and require holistic systems
research. Development of computerized algorithmic
modelling of dynamical systems and networks will
be essential to reaching an understanding of the con-
current, synergistic contributions of multiple systems
on body–mind outcomes 28–32.
The beauty of the body–mind network model is
that it can combine constitutional personality factors
(such as emotions and feelings) with bodily symp-
toms into a single diagnostic and treatment paradigm.
In TCM terms, this diagnostic model is represented by
patterns of disharmonies in the main organ systems
and by abnormalities of qi (energy flow), essence
(energy reserves), blood, heat, and moisture. Inter-
estingly, the association within the TCM model of can-
cer predisposition with rising qi (sheng qi) or “liver
fire” (representing anger) shows some correspon-
dence with the controversial scientific evidence that
repressed anger suppresses the immune system and
may increase the risk of breast cancer in the so-called
type C personality 33–35.
3.3 Biologic Effects of Acupuncture
We propose that the clinical intervention of acupunc-
ture allows practitioners to modulate communication
within the body–mind network through concurrent
changes in multiple signalling pathways. Most evi-
dence suggests that acupuncture modulates neu-
rotransmitters, cytokines, and neuropeptides through
electrophysiologic changes in the nervous sys-
tem 36,37. As the activity of afferent peripheral nerves
is either stimulated or suppressed, interactions with
the brain stem, hypothalamus, limbic system, and
autonomic nervous system occur 38–47. Acupuncture
has also been reported to modify the somatic electro-
magnetic field 48, but research in that area remains
quite controversial.
Recent research suggests that the initial trans-
duction of the acupuncture needle is through
myofascial tissue planes. The network of acupunc-
ture points and meridians can be viewed as a repre-
sentation of the network formed by interstitial
connective tissue. Langevin and Yandow mapped
acupuncture points in serial gross anatomic sections
through the human arm 49. In post-mortem tissue
sections, they found an 80% correspondence between
the sites of acupuncture points and the location of
intermuscular or intramuscular connective tissue
planes. The surface points appear to connect to a web
of vessels that cover internal organs, as demonstrated
by special DNA staining 50. The de qi (“needle grasp”)
effect may be attributable to mechanical coupling
between the needle and the connective tissue with
winding of tissue around the needle during needle
rotation. Needle manipulation could transmit a me-
chanical signal to connective tissue cells via
mechanotransduction 51. That signal may be con-
verted into an electrophysiologic response through
a change in electrical impedance that spreads through
the connective tissue planes, interacts with cellular
genomic expression, and releases local cytokines and
other messenger molecules that may initiate neuro-
logic transmission 52.
In view of the power of the placebo effect, a sham
acupuncture control arm is required as a standard for
randomized controlled trials of acupuncture. Sham
needles have been validated to a limited extent. The
results may depend on whether the subject has had
past experience of acupuncture. These devices with-
draw a blunt needle back into the sheath during ap-
plication, a sham technique that is more valid thanSAGAR and WONG
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using superficial penetration of the skin or randomly
assigning points away from known meridians.
Evaluation of the widely used Streitberger sham
needle concluded that most patients were unable to
discriminate between the needles by actual penetra-
tion; however, nearly 40% perceived a difference in
treatment type between sham and actual needles 53.
The fact that nearly 40% of subjects perceived dis-
similarities in the two interventions raises some con-
cerns with regard to the wholesale adoption of this
instrument as a standard acupuncture placebo. The
authors of the study concluded that further work on
between-tester reliability and standardization of tech-
nique is highly recommended before the Streitberger
needle can be confidently used in future studies.
3.4 Pharmacology of Chinese Herbs
In TCM, herbs are used in combinations meant to en-
hance their benefits and simultaneously to reduce their
side effects 54. In effect, multiple low-dose pharma-
cologic agents are being administered synergistically.
Western medicine usually focuses on maximally tol-
erated doses of single agents, but chemotherapy drugs
are typically combined, usually to minimize drug re-
sistance. The consequence of such combination can
be a further increase in drug toxicity. According to
TCM practitioners, combinations of herbs can reduce
the side effects of anticancer drugs; however, further
research with herbs is indicated to determine their
pharmacokinetic interactions with pharmaceutical
drugs and their potential adverse effects.
A scientific approach to introducing Chinese
herbs into Western practice involves a rigorous and
systematic approach to phytochemical profiling, qual-
ity control, preclinical evaluation, safety evaluation,
and phase I–III clinical trials (Figure 1). More data are
required to establish optimal combinations of herbs
that produce synergistic activity. Traditionally, Chi-
nese herbs have been used as complex mixtures.
One study evaluated the DNA microarray data for
12,600 genes to examine the antiproliferative activity
of the single herb Coptidis rhizoma and 8 constituent
molecules against 8 human pancreatic cancer cell
lines 55. It identified 27 genes showing a strong corre-
lation with the 50% inhibitory dose (ID50) of
C. rhizoma after a 72-hour exposure. Hierarchical clus-
ter analysis used correlation coefficients between ex-
pression levels of those 27 genes and the ID50 of each
constituent molecule to classify the test molecules into
two clusters: one consisting of C. rhizoma and ber-
berine, and the other consisting of the remaining seven
molecules. The results suggest that one specific phyto-
chemical, berberine, can account for most of the
antiproliferative activity of C. rhizoma and that DNA
microarray analyses can be used to improve our un-
derstanding of the actions of an intact herb.
In contrast, there can be merit in using combina-
tions of herbs and their derivatives. For example,
PHY106 (Radix scutellariae, Paeonia lactiflora Pall,
Fructus ziziphi, Radix glycyrrhizae) is an authenticated
combination of herbs that may increase the efficacy
and reduce the adverse effects of the cytotoxic drug
capecitabine, which is used in treating colorectal can-
cer 56. The biotechnology company PhytoCeutica
(New Haven, CT, U.S.A.) has systematically profiled
the phytochemical content of each herb and tested
various combinations at the preclinical stage to opti-
mize the complex mixture. Quality has been assured
by establishing profiles using chemical chromatogra-
phy and spectroscopy, together with biologic,
proteomic, and genomic profiling. Through these tech-
niques, Phytoceutica developed a Phytomics Similar-
ity Index. Interestingly, their modern technological
approach confirms the TCM theory of optimizing effi-
cacy through a hierarchy of herb combinations. The
PHY106 combination enhances antitumour activity,
reduces toxicity, and enhances the pharmacokinetics
of the chief herb (the “Emperor herb”). Mechanisms
include inhibiting drug resistance proteins that may
decrease absorption, inhibiting cytochrome P450 en-
zymes that metabolize phytochemicals, inhibiting
microfloral b-glucuronidase, chemical stabilization,
and modification of solubility.
Initial clinical trials demonstrate a reduction of
gastrointestinal toxicity and enhancement of the
tumoricidal effect of the chemotherapy. Many pre-
clinical studies are now demonstrating that specific
combinations of Chinese herbs can be synergistic with
FIGURE 1 Systematic scientific approach for introducing Chinese
herbs into Western clinical practice.CHINESE MEDICINE AND BIOMODULATION IN CANCER PATIENTS
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cytotoxic chemotherapy through both pharmacody-
namic and pharmacokinetic interactions. For ex-
ample, Phellinus linteus is a mushroom that consists
mainly of polysaccharides. It sensitized an in vitro
prostate cancer cell line to apoptosis induced by doxo-
rubicin 57. At relatively low doses, neither P. linteus
nor doxorubicin independently induced apoptosis in
the cells. However, combination treatment with low
doses of both agents resulted in a synergistic effect
on the induction of apoptosis. Together with doxoru-
bicin, P. linteus has a synergistic effect to activate
caspases in LNCaP prostate cancer cells. Sensitization
can be obtained at subtoxic concentrations of doxo-
rubicin. As an apoptotic synergizer for conventional
chemotherapeutics such as doxorubicin, P. linteus can
reduce normal-tissue toxicity and increase therapeu-
tic gain.
Gene expression profiling coupled with promoter
assays can evaluate the effect of a herbal mixture on
cancer. Such an approach may be used for the stan-
dardization of herbal extract activity. An example is
the comparison of the gene profile of PC-SPES with
that of PC-CARE, a product with a similar herbal
composition. Early studies showed that PC-SPES
contains estrogenic organic compounds, and such
compounds are known to have an impact on prostate
cancer. An important question is whether those com-
pounds are the primary drivers of the gene profile.
The data indicate that the gene expression profiles of
LNCaP human prostate cancer cells in response to
PC-SPES are different from those produced when di-
ethylstilbestrol (DES), a synthetic estrogen, is used,
suggesting that the estrogenic moieties within
PC-SPES do not drive the relevant expression signa-
ture 58. In contrast, the expression profile of the cells
in the presence of PC-CARE is almost identical to
that observed with DES, indicating that mixtures con-
taining similar herbs do not necessarily result in simi-
lar biologic activity.
To validate the expression profiling data, the in-
vestigators evaluated the protein expression and pro-
moter activity of prostate-specific antigen (PSA), a
gene induced by PC-SPES, but repressed by DES. To
gain a mechanistic understanding of different effects
of PC-SPES and DES on PSA expression, LNCaP cells
were transiently transfected with wild-type and
mutagenized PSA promoter, androgen response ele-
ment (ARE) concatemers, and appropriate controls.
The evidence suggested that AREs II and III within the
promoter region are responsible for the suppressive
effects of DES and stimulatory effects of PC-SPES. In
the case of DES, the effects on PSA transcription are
specific to ARE, but PC-SPES affects the promoter
non-specifically. The expression profiling, coupled
with mechanistic target validation, yields valuable
clues as to the mode of action of complex botanical
mixtures and provides a new way to objectively com-
pare mixtures that contain similar components either
for effect or for quality assurance before they are used
in clinical trials. In the case of PC-SPES, the effec-
tiveness of the complex mixture of herbs has been
shown in a randomized controlled clinical trial to be
more effective than DES alone 59.
Current technology is demonstrating the multi-
dimensional activities of Chinese herbs as antican-
cer agents. Many are potent antioxidants that can
induce apoptosis; others are anti-angiogenic
agents 60,61. Many of the herbs that are traditionally
considered effective against cancer cells are now
being shown to have subtle effects on genetic expres-
sion; they may play a key role in anticancer treat-
ment through synergistic activity with cytotoxic
agents and maintenance regimens for prevention of
recurrence 62.
Future research should maximize the use of tech-
nology to validate scientific mechanisms for quality
assurance, safety, optimization, and clinical effective-
ness within the modern cancer treatment environ-
ment 63. Rigorous adherence to the development of
research protocols and standards of reporting are nec-
essary, as stated by a recent publication of the Con-
solidated Standards of Reporting Trials group, which
establishes the standards for clinical trials of natural
health products 64. Further development of Chinese
herbal medicine for administration in Western can-
cer clinics will require both international collabora-
tion and an improved working relationship between
national governments, industries, and universities.
4. CONCLUSIONS
The health model of Chinese medicine accommodates
physical and pharmacologic interventions within the
framework of a body–mind network. A Cartesian split
does not occur within this model, but to allow for sci-
entific exploration within the restrictions of positiv-
ism, reductionism, and controls for confounding
factors, separation of the components is necessary. To
evaluate effectiveness when applying the full model
in clinical practice, whole-systems research is impor-
tant. Considering relevant individual processes and
contextual factors enhances the external validity of
clinical research 65. A whole system is not like a drug
with a specific action; rather, it produces effects that
involve global shifts across multiple subsystems of
the individual 66. However, at the opposite end of the
epistemologic spectrum, scientific dissection enables
a mechanistic understanding of the processes that will
improve the design of clinical studies and enhance
safety.
Part two of our review will dissect out some of
the specific roles for TCM in biomodulation from a
mechanistic Western science perspective.
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